Coexistence of depressive symptoms in patients with diagnosed acne vulgaris and psoriasis vulgaris

The aim of the study was a detailed analysis of the occurrence and degree of severity of depressive symptoms for patients with skin diseases in comparison to patients who have no history of skin diseases.

An assessment of the severity of depressive symptoms has been made by using the 21-point Beck Depression Inventory for patients with diagnosed psoriasis and acne in comparison with a control group of patients. Data analysis was performed with respect to information contained in the questionnaires completed by a total of 487 respondents.

In terms of the percentage distribution of depression symptoms according to the Beck Depression Inventory, statistically significant differences (Pearson 2 = 45, p = 0.0001) between the treated and control groups have been shown. The average scores of the Beck Depression Inventory were higher for the tested group and amounted to 5.11 points among patients suffering from acne (control group 3.83 points), and for patients with psoriasis 5.66 points (control group 3.97 points). Moderate depression symptoms were present for as many as 21% of acne patients and for 18% of patients with psoriasis, while severe depression symptoms were noticed for 4% of patients receiving acne treatment and for 8% of patients treated for psoriasis. In response to the question of being willing to commit suicide, as many as 9.7% of patients with acne and 4.1% of patients with psoriasis expressed their affirmation.

Psoriasis and acne have a significant impact on the mental state of patients. Symptoms of depression and anxiety disorders are significantly worse for those patients.